-
1
-
-
0030882856
-
Alpha-synuclein in Lewy bodies
-
Spillantini MG, et al. (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840.
-
(1997)
Nature
, vol.388
, pp. 839-840
-
-
Spillantini, M.G.1
-
2
-
-
0030744876
-
Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease
-
Polymeropoulos MH, et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–2047.
-
(1997)
Science
, vol.276
, pp. 2045-2047
-
-
Polymeropoulos, M.H.1
-
3
-
-
0031990490
-
Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease
-
Krüger R, et al. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat Genet 18:106–108.
-
(1998)
Nat Genet
, vol.18
, pp. 106-108
-
-
Krüger, R.1
-
4
-
-
10744230149
-
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
-
Zarranz JJ, et al. (2004) The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164–173.
-
(2004)
Ann Neurol
, vol.55
, pp. 164-173
-
-
Zarranz, J.J.1
-
5
-
-
0242300619
-
Alpha-Synuclein locus triplication causes Parkinson’s disease
-
Singleton AB, et al. (2003) alpha-Synuclein locus triplication causes Parkinson’s disease. Science 302:841.
-
(2003)
Science
, vol.302
, pp. 841
-
-
Singleton, A.B.1
-
6
-
-
4644290985
-
Α-synuclein locus duplication as a cause of familial Parkinson’s disease
-
Chartier-Harlin M-C, et al. (2004) α-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 364:1167–1169.
-
(2004)
Lancet
, vol.364
, pp. 1167-1169
-
-
Chartier-Harlin, M.-C.1
-
7
-
-
84994853544
-
Α-Synuclein-based animal models of Parkinson’s disease: Challenges and opportunities in a new era
-
Visanji NP, et al. (2016) α-Synuclein-based animal models of Parkinson’s disease: Challenges and opportunities in a new era. Trends Neurosci 39:750–762.
-
(2016)
Trends Neurosci
, vol.39
, pp. 750-762
-
-
Visanji, N.P.1
-
8
-
-
85027934032
-
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson’s disease?
-
Volpicelli-Daley LA, Kirik D, Stoyka LE, Standaert DG, Harms AS (2016) How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson’s disease? J Neurochem 139:131–155.
-
(2016)
J Neurochem
, vol.139
, pp. 131-155
-
-
Volpicelli-Daley, L.A.1
Kirik, D.2
Stoyka, L.E.3
Standaert, D.G.4
Harms, A.S.5
-
9
-
-
84856570373
-
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons
-
Decressac M, Mattsson B, Lundblad M, Weikop P, Björklund A (2012) Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons. Neurobiol Dis 45:939–953.
-
(2012)
Neurobiol Dis
, vol.45
, pp. 939-953
-
-
Decressac, M.1
Mattsson, B.2
Lundblad, M.3
Weikop, P.4
Björklund, A.5
-
10
-
-
58149380755
-
Targeted overexpression of human α-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease
-
Theodore S, Cao S, McLean PJ, Standaert DG (2008) Targeted overexpression of human α-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol 67:1149–1158.
-
(2008)
J Neuropathol Exp Neurol
, vol.67
, pp. 1149-1158
-
-
Theodore, S.1
Cao, S.2
McLean, P.J.3
Standaert, D.G.4
-
11
-
-
63849332293
-
Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV α-synucleinopathy
-
Chung CY, Koprich JB, Siddiqi H, Isacson O (2009) Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV α-synucleinopathy. J Neurosci 29: 3365–3373.
-
(2009)
J Neurosci
, vol.29
, pp. 3365-3373
-
-
Chung, C.Y.1
Koprich, J.B.2
Siddiqi, H.3
Isacson, O.4
-
12
-
-
77649294300
-
Microglia acquire distinct activation profiles depending on the degree of α-synuclein neuropathology in a rAAV based model of Parkinson’s disease
-
Sanchez-Guajardo V, Febbraro F, Kirik D, Romero-Ramos M (2010) Microglia acquire distinct activation profiles depending on the degree of α-synuclein neuropathology in a rAAV based model of Parkinson’s disease. PLoS One 5:e8784.
-
(2010)
Plos One
, vol.5
-
-
Sanchez-Guajardo, V.1
Febbraro, F.2
Kirik, D.3
Romero-Ramos, M.4
-
13
-
-
84869109864
-
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice
-
Luk KC, et al. (2012) Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949–953.
-
(2012)
Science
, vol.338
, pp. 949-953
-
-
Luk, K.C.1
-
14
-
-
84862609075
-
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
-
Luk KC, et al. (2012) Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J Exp Med 209: 975–986.
-
(2012)
J Exp Med
, vol.209
, pp. 975-986
-
-
Luk, K.C.1
-
15
-
-
80053613574
-
Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death
-
Volpicelli-Daley LA, et al. (2011) Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57–71.
-
(2011)
Neuron
, vol.72
, pp. 57-71
-
-
Volpicelli-Daley, L.A.1
-
16
-
-
84907033533
-
Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates
-
Volpicelli-Daley LA, Luk KC, Lee VM-Y (2014) Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc 9:2135–2146.
-
(2014)
Nat Protoc
, vol.9
, pp. 2135-2146
-
-
Volpicelli-Daley, L.A.1
Luk, K.C.2
Lee, V.M.-Y.3
-
17
-
-
84934955012
-
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
-
Paumier KL, et al. (2015) Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol Dis 82:185–199.
-
(2015)
Neurobiol Dis
, vol.82
, pp. 185-199
-
-
Paumier, K.L.1
-
18
-
-
84934983329
-
Α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
-
Peelaerts W, et al. (2015) α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340–344.
-
(2015)
Nature
, vol.522
, pp. 340-344
-
-
Peelaerts, W.1
-
19
-
-
84991672003
-
Molecular and biological compatibility with host alpha-synuclein influences fibril pathogenicity
-
Luk KC, et al. (2016) Molecular and biological compatibility with host alpha-synuclein influences fibril pathogenicity. Cell Rep 16:3373–3387.
-
(2016)
Cell Rep
, vol.16
, pp. 3373-3387
-
-
Luk, K.C.1
-
20
-
-
58849107919
-
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease
-
Brochard V, et al. (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119: 182–192.
-
(2009)
J Clin Invest
, vol.119
, pp. 182-192
-
-
Brochard, V.1
-
21
-
-
84984787903
-
Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease
-
Rey NL, et al. (2016) Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease. J Exp Med 213: 1759–1778.
-
(2016)
J Exp Med
, vol.213
, pp. 1759-1778
-
-
Rey, N.L.1
-
22
-
-
84959541277
-
Targeting α-synuclein: Therapeutic options
-
Dehay B, et al. (2016) Targeting α-synuclein: Therapeutic options. Mov Disord 31: 882–888.
-
(2016)
Mov Disord
, vol.31
, pp. 882-888
-
-
Dehay, B.1
-
23
-
-
23644443643
-
Gene expression profiling of Lewy body-bearing neurons in Parkinson’s disease
-
Lu L, et al. (2005) Gene expression profiling of Lewy body-bearing neurons in Parkinson’s disease. Exp Neurol 195:27–39.
-
(2005)
Exp Neurol
, vol.195
, pp. 27-39
-
-
Lu, L.1
-
24
-
-
70449532484
-
A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death
-
Greffard S, et al. (2010) A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging 31:99–103.
-
(2010)
Neurobiol Aging
, vol.31
, pp. 99-103
-
-
Greffard, S.1
-
25
-
-
84924554924
-
Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism
-
Osterberg VR, et al. (2015) Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism. Cell Rep 10:1252–1260.
-
(2015)
Cell Rep
, vol.10
, pp. 1252-1260
-
-
Osterberg, V.R.1
-
26
-
-
0035834360
-
Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
-
Conway KA, Rochet JC, Bieganski RM, Lansbury PT, Jr (2001) Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct. Science 294:1346–1349.
-
(2001)
Science
, vol.294
, pp. 1346-1349
-
-
Conway, K.A.1
Rochet, J.C.2
Bieganski, R.M.3
Lansbury, P.T.4
-
27
-
-
23444455247
-
Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway
-
Cappai R, et al. (2005) Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J 19:1377–1379.
-
(2005)
FASEB J
, vol.19
, pp. 1377-1379
-
-
Cappai, R.1
-
28
-
-
20144389524
-
Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson’s disease
-
Zhang W, et al. (2005) Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson’s disease. FASEB J 19:533–542.
-
(2005)
FASEB J
, vol.19
, pp. 533-542
-
-
Zhang, W.1
-
29
-
-
79955660630
-
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
-
Lee H-J, et al. (2011) Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers. Exp Mol Med 43:216–222.
-
(2011)
Exp Mol Med
, vol.43
, pp. 216-222
-
-
Lee, H.-J.1
-
30
-
-
0023740773
-
Rate of cell death in parkinsonism indicates active neuropathological process
-
McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24:574–576.
-
(1988)
Ann Neurol
, vol.24
, pp. 574-576
-
-
McGeer, P.L.1
Itagaki, S.2
Akiyama, H.3
McGeer, E.G.4
-
31
-
-
84878508881
-
MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration
-
Harms AS, et al. (2013) MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci 33: 9592–9600.
-
(2013)
J Neurosci
, vol.33
, pp. 9592-9600
-
-
Harms, A.S.1
-
32
-
-
84875898265
-
Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia
-
Kim C, et al. (2013) Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun 4:1562.
-
(2013)
Nat Commun
, vol.4
, pp. 1562
-
-
Kim, C.1
-
33
-
-
84965046341
-
Inhibition of the JAK/STAT pathway protects against α-synuclein-induced neuroinflammation and dopaminergic neurodegeneration
-
Qin H, et al. (2016) Inhibition of the JAK/STAT pathway protects against α-synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J Neurosci 36: 5144–5159.
-
(2016)
J Neurosci
, vol.36
, pp. 5144-5159
-
-
Qin, H.1
-
34
-
-
84869861952
-
The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia
-
Cao S, Standaert DG, Harms AS (2012) The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia. J Neuroinflammation 9:259.
-
(2012)
J Neuroinflammation
, vol.9
, pp. 259
-
-
Cao, S.1
Standaert, D.G.2
Harms, A.S.3
-
35
-
-
84893858665
-
Extracellular α-synuclein–A novel and crucial factor in Lewy body diseases
-
Lee H-J, Bae E-J, Lee S-J (2014) Extracellular α-synuclein–A novel and crucial factor in Lewy body diseases. Nat Rev Neurol 10:92–98.
-
(2014)
Nat Rev Neurol
, vol.10
, pp. 92-98
-
-
Lee, H.-J.1
Bae, E.-J.2
Lee, S.-J.3
-
36
-
-
80051985178
-
GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson’s disease
-
Decressac M, et al. (2011) GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson’s disease. Brain 134:2302–2311.
-
(2011)
Brain
, vol.134
, pp. 2302-2311
-
-
Decressac, M.1
-
37
-
-
84969915719
-
Α-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter
-
Wan OW, et al. (2016) α-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter. Sci Rep 6:26285.
-
(2016)
Sci Rep
, vol.6
, pp. 26285
-
-
Wan, O.W.1
-
38
-
-
0031983453
-
In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: Effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions
-
Hoffman AF, Gerhardt GA (1998) In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: Effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions. J Neurochem 70:179–189.
-
(1998)
J Neurochem
, vol.70
, pp. 179-189
-
-
Hoffman, A.F.1
Gerhardt, G.A.2
-
40
-
-
84857716290
-
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons
-
Lundblad M, Decressac M, Mattsson B, Björklund A (2012) Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons. Proc Natl Acad Sci USA 109:3213–3219.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, pp. 3213-3219
-
-
Lundblad, M.1
Decressac, M.2
Mattsson, B.3
Björklund, A.4
|